Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

Clinical trial NCT07061717 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07061717
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

Start date: 2025-07-01
Primary completion: 2029-07-01
Enrollment: 474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.